Jane Street
VTVT icon

Jane Street’s vTv Therapeutics VTVT Stock Holding History

Jane Street’s Portfolio VTVT Stock Details VTVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-349
Closed -$14K – 11093
2021
Q4 		$14K Buy
+349
New +$18.7K ﹤0.01% 9863
2021
Q3 		– Sell
-1,832
Closed -$167K – 10814
2021
Q2 		$167K Buy
+1,832
New +$186K ﹤0.01% 8961
2020
Q4 		– Sell
-395
Closed -$28K – 8177
2020
Q3 		$28K Sell
395
-163
-29% -$14.3K ﹤0.01% 7004
2020
Q2 		$50K Buy
+558
New +$55.1K ﹤0.01% 6867
2018
Q3 		– Sell
-622
Closed -$38K – 5767
2018
Q2 		$38K Buy
+622
New +$45.9K ﹤0.01% 4838

Other funds holding VTVT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Jane Street's VTVT Position: Q1 2022 in Review

Jane Street sold out of vTv Therapeutics (VTVT) in Q1 2022, closing a stake of 349 shares — an estimated $14K sold.

Jane Street first reported a position in VTVT in Q2 2018 and held it in 5 quarters. The position peaked at $167K in Q2 2021. 24 funds tracked by Wall St. Rank hold VTVT as of Q1 2022.

  • Jane Street reported no remaining vTv Therapeutics position as of Q1 2022 after selling out during the quarter.
  • Jane Street sold 349 vTv Therapeutics shares in Q1 2022, an estimated $14K.
  • Jane Street first reported a position in vTv Therapeutics in Q2 2018 and held it in 5 quarters.
  • Jane Street's vTv Therapeutics position peaked at $167K in Q2 2021.
  • 24 funds tracked by Wall St. Rank held vTv Therapeutics as of Q1 2022.

Based on Jane Street's 13F filing for Q1 2022, filed 17 May 2022.